DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Dummer R, Schadendorf D, Ascierto P et al.
Results of NEMO: A phase III trial of binimetinib (BINI) vs dacarbazine (DTIC) in NRAS-mutant cutaneous melanoma.
J Clin Oncol 2016; 34
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.